Almirall, S.A.

BME:ALM 株式レポート

時価総額:€1.8b

Almirall 過去の業績

過去 基準チェック /06

Almirallの収益は年間平均-62.1%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間13.1% 1%割合で 増加しています。

主要情報

-62.1%

収益成長率

-61.0%

EPS成長率

Pharmaceuticals 業界の成長5.0%
収益成長率1.0%
株主資本利益率-2.4%
ネット・マージン-3.8%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

Almirall (BME:ALM) Has A Somewhat Strained Balance Sheet

Nov 06
Almirall (BME:ALM) Has A Somewhat Strained Balance Sheet

Investors Continue Waiting On Sidelines For Almirall, S.A. (BME:ALM)

Sep 07
Investors Continue Waiting On Sidelines For Almirall, S.A. (BME:ALM)

Almirall, S.A.'s (BME:ALM) Intrinsic Value Is Potentially 90% Above Its Share Price

Jul 12
Almirall, S.A.'s (BME:ALM) Intrinsic Value Is Potentially 90% Above Its Share Price

Market Participants Recognise Almirall, S.A.'s (BME:ALM) Revenues

Apr 24
Market Participants Recognise Almirall, S.A.'s (BME:ALM) Revenues

These 4 Measures Indicate That Almirall (BME:ALM) Is Using Debt Reasonably Well

Mar 20
These 4 Measures Indicate That Almirall (BME:ALM) Is Using Debt Reasonably Well

Here's Why Almirall (BME:ALM) Can Manage Its Debt Responsibly

Dec 15
Here's Why Almirall (BME:ALM) Can Manage Its Debt Responsibly

Is There An Opportunity With Almirall, S.A.'s (BME:ALM) 21% Undervaluation?

Oct 03
Is There An Opportunity With Almirall, S.A.'s (BME:ALM) 21% Undervaluation?

We Think Almirall (BME:ALM) Can Stay On Top Of Its Debt

Aug 24
We Think Almirall (BME:ALM) Can Stay On Top Of Its Debt

Is There An Opportunity With Almirall, S.A.'s (BME:ALM) 31% Undervaluation?

Jul 05
Is There An Opportunity With Almirall, S.A.'s (BME:ALM) 31% Undervaluation?

Is Almirall (BME:ALM) A Risky Investment?

May 16
Is Almirall (BME:ALM) A Risky Investment?

Estimating The Fair Value Of Almirall, S.A. (BME:ALM)

Mar 29
Estimating The Fair Value Of Almirall, S.A. (BME:ALM)

We Think Almirall (BME:ALM) Can Stay On Top Of Its Debt

Jan 04
We Think Almirall (BME:ALM) Can Stay On Top Of Its Debt

An Intrinsic Calculation For Almirall, S.A. (BME:ALM) Suggests It's 29% Undervalued

Dec 01
An Intrinsic Calculation For Almirall, S.A. (BME:ALM) Suggests It's 29% Undervalued

Almirall (BME:ALM) Seems To Use Debt Quite Sensibly

Jul 14
Almirall (BME:ALM) Seems To Use Debt Quite Sensibly

Here's Why Almirall (BME:ALM) Can Manage Its Debt Responsibly

Mar 23
Here's Why Almirall (BME:ALM) Can Manage Its Debt Responsibly

Almirall, S.A.'s (BME:ALM) Intrinsic Value Is Potentially 82% Above Its Share Price

Feb 24
Almirall, S.A.'s (BME:ALM) Intrinsic Value Is Potentially 82% Above Its Share Price

Is Almirall (BME:ALM) Using Too Much Debt?

Nov 01
Is Almirall (BME:ALM) Using Too Much Debt?

Almirall, S.A.'s (BME:ALM) Intrinsic Value Is Potentially 77% Above Its Share Price

Aug 02
Almirall, S.A.'s (BME:ALM) Intrinsic Value Is Potentially 77% Above Its Share Price

Is Almirall (BME:ALM) Using Too Much Debt?

Jul 06
Is Almirall (BME:ALM) Using Too Much Debt?

Here's Why Almirall (BME:ALM) Has A Meaningful Debt Burden

Mar 23
Here's Why Almirall (BME:ALM) Has A Meaningful Debt Burden

How Does Almirall, S.A. (BME:ALM) Fare As A Dividend Stock?

Mar 05
How Does Almirall, S.A. (BME:ALM) Fare As A Dividend Stock?

Almirall, S.A. (BME:ALM) Shares Could Be 41% Below Their Intrinsic Value Estimate

Feb 15
Almirall, S.A. (BME:ALM) Shares Could Be 41% Below Their Intrinsic Value Estimate

収支内訳

Almirall の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

BME:ALM 収益、費用、利益 ( )EUR Millions
日付収益収益G+A経費研究開発費
30 Jun 24932-352200
31 Mar 24915-392143
31 Dec 23899-382090
30 Sep 2390772097
30 Jun 23898-112010
31 Mar 23882-82053
31 Dec 2287942020
30 Sep 22864920724
30 Jun 22856291970
31 Mar 22843-501908
31 Dec 21837-411880
30 Sep 21814-22201-10
30 Jun 21809-111850
31 Mar 2179055188-8
31 Dec 20814741770
30 Sep 2084963167-8
30 Jun 20872861880
31 Mar 209261211880
31 Dec 199111061890
30 Sep 19858852279
30 Jun 19884881820
31 Mar 19789802093
31 Dec 18811781830
30 Sep 18714-111176-10
30 Jun 18730-1791960
31 Mar 18687-293195-6
31 Dec 17677-3042070
30 Sep 17735-1282155
30 Jun 17755-782140
31 Mar 17821732165
31 Dec 16822752130
30 Sep 1677816223010
30 Jun 167431542100
31 Mar 167211112042
31 Dec 157381322010
30 Sep 15783479190-28
30 Jun 158024882440
31 Mar 15842481250-11
31 Dec 148284482740
30 Sep 14868-13262-11
30 Jun 14849-322560
31 Mar 14845-332610
31 Dec 13825-342500

質の高い収益: ALMは現在利益が出ていません。

利益率の向上: ALMは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: ALMは利益が出ておらず、過去 5 年間で損失は年間62.1%の割合で増加しています。

成長の加速: ALMの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: ALMは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 8.8% ) と比較することは困難です。


株主資本利益率

高いROE: ALMは現在利益が出ていないため、自己資本利益率 ( -2.36% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘